Veracity Clinical Research   Report issue

For profit Phase 1 Phase 2
Founded: Woolloongabba Australia (1989)

Organization Overview

First Clinical Trial
2013
NCT02097875
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Veracity Clinical Research Pty Ltd.

Active Ingredients

Drugs in Phase 2 Trials (3)

acebilustat (1 trial)

fluorouracil (efudex) (1 trial)

Gusacitinib (1 trial)

Drugs in Phase 1 Trials (1)

tozuleristide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Basal Cell Nevus Syndrome (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Skin Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4